Armin Atzinger
Impact in
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
-
- Protease and Inhibitor Mechanisms
Papers in
- Oncology 11
- Peptidase Inhibition and Analysis 9
-
- Protease and Inhibitor Mechanisms 6
- Co-authors
- Torsten Kuwert (21 shared papers)Christian Schmidkonz (16 shared papers)Georg Schett (11 shared papers)Arnd Kleyer (6 shared papers)Andreas Ramming (7 shared papers)Michael Uder (4 shared papers)M. Cordes (5 shared papers)Jule Taubmann (3 shared papers)
In The Last Decade
Armin Atzinger
24 papers receiving 278 citations
Armin Atzinger's Hit Papers
Peers
Comparison fields: 5 of 34
- Oncology 144
- Cancer Research 37
- Radiology, Nuclear Medicine and Imaging 54
- Rheumatology 28
- Immunology 39
Countries citing papers authored by Armin Atzinger
This map shows the geographic impact of Armin Atzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Atzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Atzinger more than expected).
Fields of papers citing papers by Armin Atzinger
This network shows the impact of papers produced by Armin Atzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Atzinger. The network helps show where Armin Atzinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Armin Atzinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 63 | |
| 2 | 2022 | 42 | |
| 3 | BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells Hit paper breakdown → | 2025 | 25 |
| 4 | 2022 | 23 | |
| 5 | 2023 | 22 | |
| 6 | 2019 | 17 | |
| 7 | 2024 | 17 | |
| 8 | 2020 | 13 | |
| 9 | 2024 | 11 | |
| 10 | 2022 | 7 | |
| 11 | 2019 | 7 | |
| 12 | 2024 | 6 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2025 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2025 | 1 |
About Armin Atzinger
Armin Atzinger is a scholar working on Oncology, Cancer Research, Rheumatology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 27 papers that have together received 280 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (9 papers), Protease and Inhibitor Mechanisms (6 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Inflammatory Myopathies and Dermatomyositis (3 papers), Spondyloarthritis Studies and Treatments (3 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Oncology (144 citations), Cancer Research (37 citations), Radiology, Nuclear Medicine and Imaging (54 citations), Rheumatology (28 citations) and Immunology (39 citations). Armin Atzinger has collaborated with scholars based in Germany, Portugal and Ireland. Frequent co-authors include Torsten Kuwert, Christian Schmidkonz, Georg Schett, Arnd Kleyer, Andreas Ramming, Michael Uder, M. Cordes, Jule Taubmann, Simon Völkl and Frank W. Roemer. Their work appears in journals such as Annals of the Rheumatic Diseases, RMD Open, Journal of Nuclear Medicine, Lara D. Veeken and Nuklearmedizin - NuclearMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.